CeriBell, Inc Total Assets
CeriBell, Inc total assets. Based on the latest financial reports, CeriBell, Inc (CBLL) holds total assets worth $166.35 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of CeriBell, Inc for the company's overall valuation and market capitalisation.
Total Assets of CeriBell, Inc (2022–2025)
Total assets of CeriBell, Inc from 2022 to 2025. This chart illustrates how CeriBell, Inc's total assets have evolved over time, based on quarterly financial data. See CBLL live share price for real-time trading data and today's change.
CeriBell, Inc - Asset Composition Analysis
CeriBell, Inc Total Assets Breakdown (December 2025)
CeriBell, Inc total assets breakdown as of December 2025. CeriBell, Inc's total assets of $166.35 Million consist of 95.4% current assets and 4.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 20.7% |
| Accounts Receivable | $15.05 Million | 7.7% |
| Inventory | $7.29 Million | 3.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $805.00K | 0.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how CeriBell, Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CBLL working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CeriBell, Inc's current assets represent 95.4% of total assets in 2025, an increase from 92.3% in 2022.
- Cash Position: Cash and equivalents constituted 20.7% of total assets in 2025, down from 78.9% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 7.7% of total assets.
CeriBell, Inc Competitors by Total Assets
Key competitors of CeriBell, Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
CeriBell, Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.18 | 13.31 | 2.41 |
| Quick Ratio | 8.79 | 12.91 | 2.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $140.65 Million | $184.77 Million | $30.36 Million |
CeriBell, Inc - Advanced Valuation Insights
This section examines the relationship between CeriBell, Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.07 |
| Latest Market Cap to Assets Ratio | 4.54 |
| Asset Growth Rate (YoY) | -13.1% |
| Total Assets | $195.80 Million |
| Market Capitalization | $888.45 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values CeriBell, Inc's assets at a significant premium (4.54x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: CeriBell, Inc's assets decreased by 13.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for CeriBell, Inc (2022–2025)
The table below shows the annual total assets of CeriBell, Inc from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $195.80 Million | -13.14% |
| 2024-12-31 | $225.41 Million | +282.56% |
| 2023-12-31 | $58.92 Million | -31.85% |
| 2022-12-31 | $86.46 Million | -- |
About CeriBell, Inc
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly t… Read more